FdaApplication

ANDA 215922

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRUBICON RESEARCH LTD
application_typeANDA
approval_date2025-01-22

Products (2)

ProductActive ingredientStrengthDosage form
IVERMECTINIVERMECTIN6MGTABLET;ORAL
IVERMECTINIVERMECTIN3MGTABLET;ORAL

2 products